Heart rate-corrected QT interval: A novel diagnostic biomarker for diabetic peripheral neuropathy
Journal of Diabetes Investigation Dec 26, 2021
Jiang AJ, Gu H, Feng ZR, et al. - A more reliable diagnostic utility for diabetic peripheral neuropathy (DPN) is offered by QTc (heart rate-corrected QT) interval with 428.5ms vs nerve conduction velocity, and prolonged QTc interval is closely linked with elevated risk of DPN.
This study included 965 patients with diabetes, including 473 patients with DPN, and 492 patients without DPN; they underwent standard 12-lead electrocardiography and detailed assessments of peripheral neuropathy.
Longer QTc interval was detected in DPN cases vs those without DPN.
In participants, from the first to fourth quartile of QTc interval, the proportion of DPN cases appreciably rose and the nerve conduction velocity obviously reduced.
For DPN, the optimal cutoff point of QTc interval was 428.5ms, with sensitivity and specificity of 0.715 and 0.920, respectively.
An increase in the AUC for diagnosis of DPN (from 0.736 to 0.916) was evident when QTc interval and nerve conduction testing were combined.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries